IceCure Medical Ltd. (ICCM) Form 6-K — Aug 11, 2026

IceCure Medical announced on August 11, 2026 that director Vincent Chun Hung Chan resigned from its Board of Directors, effective August 14, 2026. The company stated that Chan's resignation was not related to any disagreement with the company on any matter relating to its operations, policies or practices. In his place, the Board appointed David Salton as an independent director and Class II director, serving until the annual general meeting of shareholders to be held in 2027. Salton will also sit on the Compensation Committee and the Audit Committee and Financial Statement Examination Committee, and will enter the company's standard indemnification and exemption agreement.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.